Please be advised that we’ve changed pharmacy software. This means the process for submitting online refills will change as well. Your previous logins and our mobile app will no longer work. Please click the Refill Now button to begin the new process. Thank you for your patience during this transition.
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV).
Following approval one month ago by the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention on Friday also approved the shot, called Abrysvo. That marks the last hurdle needed for the vaccine to become widely available.
Following on an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the U.S. Centers for Disease Control and Prevention on Tuesday also signed off on new COVID boosters for Americans.
Final approval is expected from CDC Director Dr. Mandy Cohen, which would set the stage for the updated vaccines to soon become available.
When you have COVID-19, when are you most infectious? Researchers are getting closer to an answer, with a new study finding that folks exhale the highest amounts of virus during the first eight days of their illness.
Scientists found that patients exhale quite a bit of virus during the first several days — as many as 1,000 copies of airborne virus per minute.
The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the updated vaccines to become available within days.
The COVID-19 shots from Pfizer and Moderna will join the flu shot and newly approved RSV shots as part of a three-pronged public health strategy to tame the spread of all three viruses this coming winter. The ...
You've probably heard of West Nile virus, but mosquitoes spread various other illnesses, too, including the little-known Jamestown Canyon virus (JCV), which is garnering attention across the United States.
For example, health officials in Connecticut have so far identified mosquitoes carrying JCV in 12 towns across the state. Although no confirmed human cases of the disease have occurred ...
Some good news for folks who are worried about the new, troublesome COVID variant known as BA.2.86: Moderna Inc. said Wednesday that its updated vaccine held its own against this highly mutated version of the virus.
While approval for the newest version of the vaccine is still pending from the U.S. Food and Drug Administration, the company offered good reason for why the agency should gi...
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday
The vaccine is designed to be given to pregnant women between 32 and 36 weeks of pregnancy as a way to protect infants from birth through 6 months from the sometimes ...
The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respiratory syncytial virus (RSV).
The antibody shot, sold as Beyfortus, has been shown to reduce the risk of both hospitalizations and healthcare visits for RSV in infants by about 80 percent, the CDC said in a
While both the Moderna and Pfizer COVID-19 vaccines are considered safe and highly effective, new research finds the Moderna shot has been the safest and most effective for seniors.
“The results of this study can help public health experts weigh which mRNA vaccine might be preferred for older adults and older subgroups, such as those with increased frailty,” said lead study author
People taking antiretroviral therapy to treat HIV who have low but detectable virus levels have almost zero risk of transmitting the virus to others, according to a new research review.
Researchers looked at eight studies of more than 7,700 couples in which one person was HIV positive and the other was not. The studies were done in 25 countries and reviewed by teams from the Global Health...
MONDAY, July 17, 2023 (HealthDay Now) -- Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.
Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday.
On Thursday, Dr. Rochelle Walensky, the outgoing CDC director, gave her signature to a recommendation made last week by an advisory panel of outside experts for a single dose of the vaccines made by Pfizer and GSK. The FDA ...
Having even a mild COVID-19 infection could trigger a months-long drop in sperm, a new study finds.
Researchers found both lower sperm concentrations and fewer sperm that were able to swim when studying men an average of 100 days after COVID-19 infection, which is enough time for new sperm to be produced.
“There have been previous studies that show semen quality is affected in th...
A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.
The monoclonal antibody shot would protect against respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, the New York Times reported. It could also be used for toddlers up to 24 months old who are p...
People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new research shows.
A study from Switzerland found that 17% of that group did not return to their previously normal health, and 18% reported COVID symptoms such as shortness of breath 24 months after their infection was gone.
A key to living to 100 may be the viruses living in a centenarian's guts.
“This snapshot of how the virome interacts with gut microbiomes could tell us about how microbial and viral ecology evolves over the lifetime of a person,” said Ramnik Xavier, director of immunology and co-director of the infectious ...
Researchers have developed a definition and symptom checklist for long COVID, based on initial findings from a study of nearly 10,000 Americans.
The study identified a set of 12 long-term symptoms that can occur following infection with COVID-19. These symptoms — ranging from "brain fog" to chest pain — are linked to the effects of the coronavirus on multiple organ systems.
Most cases of mpox are spread from skin-to-skin contact, but it is possible to catch the virus by touching a contaminated surface in a house or a hospital room, according to a new study.
Researchers studying this found temperature made a difference. The virus could survive at room temperature on a surface for up to 11 days. At 4 degrees Celsius (39 degrees Fahrenheit), it could survive f...
Severely obese people may need more frequent COVID-19 booster shots to keep their immunity going, new research suggests.
Protection from the shots declines more rapidly in those who are severely obese compared to those at a normal weight, according to scientists at the Universities of Cambridge and Edinburgh in the United Kingdom.
"Because of the high prevalence of obesity across ...